Initial Treatment for Chlamydia Improves Pelvic Inflammatory Disease Outcomes
Initial treatment for C trachomatis in hospitalized women with PID showed significant improvements in rates of surgical intervention and mortality.
Chlamydia
High Sensitivity, Specificity for Chlamydia Point-of-Care Test
Polymerase chain reaction test has high sensitivity and specificity for vaginal swab samples.
NYC Sexual Health Clinics See Rise in Anorectal Lymphogranuloma Venereum
A rise in anorectal lymphogranuloma venereum, caused by Chlamydia trachomatis invasive serovars, observed from 2012-2015 in NYC sexual health clinics.
CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017.
Point-of-Care Molecular Test Effectively Detects Chlamydia, Gonorrhea
A new point-of-care molecular test for CT and NG has the same accuracy as conventional nucleic acid amplification tests in certain settings.
Doxycycline Post-Exposure Prophylaxis May Prevent STIs in High-Risk MSM
In the future, doxycycline post-exposure prophylaxis might become an effective addition to a combined intervention approach to reduce the high rate of STIs in PrEP users.
Marijuana, Alcohol Intervention May Help to Reduce STIs Among Adolescents
Behavioral interventions that include sexual risk reduction combined with alcohol- and cannabis-focused elements are effective in reducing STI incidence among adolescents.
Chlamydia Infection Not Associated With Adverse Birth Outcomes
A chlamydia infection that has been identified during pregnancy and treated does not appear to result in a substantial increase in the risk of preterm birth compared with the risk in women tested and shown to not have a chlamydia infection.
Vaginal Microbiota Profile Predictive of Chlamydia Susceptibility
Vaginal microbiota dominated by L iners has been shown to exhibit rapid change in composition in and out of community states similar to bacterial vaginosis.
CDC: Cases of Chlamydia, Gonorrhea, and Syphilis Exceed 2 Million
The number of cases of chlamydia, gonorrhea, and syphilis reported in the United States exceeded 2 million in 2016.
Next post in Sexually Transmitted Diseases
